Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Physicians Often Don’t Address Their Burnout
FRIDAY, Sept. 28, 2018 (HealthDay News) — More than half of physicians experience burnout, and many do not seek treatment for burnout, according to a report published in the American Medical Association’s AMA Wire.
Implementing EMRs Affects Time Spent With Patients in Clinic
FRIDAY, Sept. 28, 2018 (HealthDay News) — Following a six-month learning period to implement an electronic medical record (EMR) system, outpatient orthopedic clinics return to pre-implementation efficiency, but there may be other lasting effects on productivity, according to a study published in the Sept. 19 issue of The Journal of Bone & Joint Surgery.
Business Degree Increasingly Useful for Doctors
THURSDAY, Sept. 27, 2018 (HealthDay News) — Having a Master of Business Administration degree (M.B.A.) can help doctors with important, practice-related decisions, according to a report published recently in Physician Practice.
Machine Learning Can Improve Chemical Toxicity Prediction
THURSDAY, Sept. 27, 2018 (HealthDay News) — Machine learning of toxological big data can predict the toxicity of chemicals, and may be more reliable than animal testing, according to a study published in the September issue of Toxicological Sciences.
Abstract/Full Text (subscription or payment may be required)
Practices Should Set Rules for Staff Social Media Use
THURSDAY, Sept. 27, 2018 (HealthDay News) — Medical practices can take steps to avoid problems related to use of social media by staff members, according to an article published in Medical Economics.
Burnout, Career Choice Regret Prevalent in U.S. Residents
WEDNESDAY, Sept. 26, 2018 (HealthDay News) — Symptoms of burnout and career choice regret are prevalent among U.S. resident physicians, according to a study published in the Sept. 18 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Novel Immunotherapy May Up Survival in Melanoma Brain Mets
TUESDAY, Sept. 25, 2018 (HealthDay News) — Checkpoint blockade immunotherapy (CBI) is associated with significant increases in overall survival (OS) in a real-world population of patients undergoing treatment for melanoma brain metastases (MBM), according to research published in the September issue of Cancer Immunology Research.
Abstract/Full Text (subscription or payment may be required)
Physician-Group ACOs Generate Medicare Savings
Psoriasis Linked to Impairment of Some Sleep Domains 
Preexisting Medical Conditions Linked to Range of Botox Injection Complications 
Chronic Pruritus Prevalent Among Older Adults 
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs 
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome 
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers 
Phelan-McDermid Syndrome More Prevalent Than Previously Estimated 
